Neuren’s Phase 2 trofinetide trial shows significant benefit in pediatric Rett syndrome
(Cincinnati, OH) The International Rett Syndrome Foundation, now doing business as Rettsyndrome.org, announces today that Neuren Pharmaceuticals reported that trofinetide had significant clinical bene..








